Federico Gago - Concepedia

Author

Federico Gago

Also Known As

F Gago, F. GAGO, F. Gago, F.J.F. Gago, Federico Gago, Federico Gago (60533), Federico. Gago, Federigo Gago, Gago, F., Gago, Federico

347

Publications

7.5K

Citations

H-Index

Concepts

All Affiliations

Universidad de Alcalá Instituto de Química Médica Rega Institute for Medical Research KU Leuven Consejo Superior de Investigaciones Científicas

About

Federico Gago is an author at Universidad de Alcalá specializing in natural sciences, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	28	53	2.2K
2	Medicine	27	52	2K
3	Biochemistry	27	48	2K
4	Engineering	16	20	972
5	Allergy	1	1	15

Federico Gago

157

Publications

6.1K

Citations

H-Index

Page 1

	Year	Citations
Prediction of Drug Binding Affinities by Comparative Binding Energy Analysis Ángel R. Ortíz, M. Teresa Pisabarro, Federico Gago, Journal of Medicinal Chemistry	1995	265
Regiospecific Synthesis and Anti-Human Immunodeficiency Virus Activity of Novel 5-Substituted <i>N</i>-Alkylcarbamoyl and <i>N,N</i>-Dialkyl Carbamoyl 1,2,3-Triazole-TSAO Analogues Sonsoles Velázquez, Rosa Álvarez, Carlos A. Perez, Antiviral chemistry & chemotherapy Bioorganic ChemistryOrganic ChemistryAntiviral DrugPharmaceutical ChemistryRegiospecific Synthesis	1998	223
Molecular Determinants of Topoisomerase I Poisoning by Lamellarins: Comparison with Camptothecin and Structure−Activity Relationships Esther Marco, William Laine, Christelle Tardy, Journal of Medicinal Chemistry EngineeringMolecular BiologyLamellarin DChemical BiologyMolecular Determinants	2005	213
Cross-Talk between Nucleotide Excision and Homologous Recombination DNA Repair Pathways in the Mechanism of Action of Antitumor Trabectedin Ana B. Herrero, Cristina Martı́n-Castellanos, Esther Marco, Cancer Research	2006	167
PM01183, a new DNA minor groove covalent binder with potent <i>in vitro</i> and <i>in vivo</i> anti‐tumour activity JFM Leal, Marta Martínez, Verónica García-Hernández, British Journal of Pharmacology	2010	149
Comparative Binding Energy Analysis of HIV-1 Protease Inhibitors: Incorporation of Solvent Effects and Validation as a Powerful Tool in Receptor-Based Drug Design Carlos A. Perez, Manuel Pastor, Ángel R. Ortíz, Journal of Medicinal Chemistry	1998	133
Guanidinium Receptors as Enantioselective Amino Acid Membrane Carriers Perla Breccia, Michiel Van Gool, Ruth Pérez‐Fernández, Journal of the American Chemical Society	2003	116
Regulation of cyclooxygenase activity by metamizol Carmen A. Campos, Rosa de Gregorio, Raquel Garcı́a-Nieto, European Journal of Pharmacology BiochemistryMedicineMechanism Of ActionSecondary MetaboliteMetabolomics	1999	97
Mutational Pathways, Resistance Profile, and Side Effects of Cyanovirin Relative to Human Immunodeficiency Virus Type 1 Strains with N-Glycan Deletions in Their gp120 Envelopes Jan Balzarini, Kristel Van Laethem, Willy J. Peumans, Journal of Virology	2006	95
Translation Elongation Factor eEF1A2 is a Novel Anticancer Target for the Marine Natural Product Plitidepsin Alejandro Losada, María José Muñoz-Alonso, Carolina García, Scientific Reports Cell SignalingMedicineApoptosisGtp ConformationCell Death	2016	94

Page 1